275 related articles for article (PubMed ID: 12932847)
21. Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Peters LE
Neurochem Int; 2023 Oct; 169():105590. PubMed ID: 37536650
[TBL] [Abstract][Full Text] [Related]
22. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
23. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
24. L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection.
Weihmuller FB; O'Dell SJ; Marshall JF
Brain Res; 1993 Oct; 623(2):303-7. PubMed ID: 8221113
[TBL] [Abstract][Full Text] [Related]
25. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
Quinton MS; Yamamoto BK
Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
[TBL] [Abstract][Full Text] [Related]
26. Dopamine and Methamphetamine Differentially Affect Electron Transport Chain Complexes and Parkin in Rat Striatum: New Insight into Methamphetamine Neurotoxicity.
Bazylianska V; Sharma A; Chauhan H; Schneider B; Moszczynska A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008791
[TBL] [Abstract][Full Text] [Related]
27. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
O'Dell SJ; Weihmuller FB; Marshall JF
Brain Res; 1991 Nov; 564(2):256-60. PubMed ID: 1810626
[TBL] [Abstract][Full Text] [Related]
28. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
29. Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats.
Cass WA; Peters LE
Neurochem Int; 2017 Sep; 108():222-229. PubMed ID: 28390950
[TBL] [Abstract][Full Text] [Related]
30. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
31. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Peters LE; Harned ME; Seroogy KB
Ann N Y Acad Sci; 2006 Aug; 1074():272-81. PubMed ID: 17105923
[TBL] [Abstract][Full Text] [Related]
32. Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.
Cass WA; Harned ME; Bailey SL
Brain Res; 2002 May; 938(1-2):29-37. PubMed ID: 12031532
[TBL] [Abstract][Full Text] [Related]
33. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Gerhardt GA; Maloney RE
Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
35. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.
Cass WA; Peters LE; Fletcher AM; Yurek DM
Neurochem Res; 2014 Aug; 39(8):1467-76. PubMed ID: 24858239
[TBL] [Abstract][Full Text] [Related]
36. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
[TBL] [Abstract][Full Text] [Related]
38. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
39. In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission.
Ferris MJ; Frederick-Duus D; Fadel J; Mactutus CF; Booze RM
Synapse; 2009 Mar; 63(3):181-5. PubMed ID: 19086089
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
